GYRE Operating Cash Flow (Statement)
Gyre Therapeutics Inc · Operating Cash Flow (Statement)
GYRE Operating Cash Flow (Statement)
Latest reported-$14.50Mperiod ending
GYRE TTM Cash from Operations (-$26.25M → -$14.50M)
TTM operating cash flow (statement)
High-resolution chart · PNG
GYRE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -14,497,000 | |
| 4,319,000 | |
| 1,010,000 | |
| 3,877,000 | |
| 877,000 | |
| -6,823,000 | |
| -3,810,000 | |
| 2,308,000 | |
| 8,214,000 | |
| 18,359,000 | |
| 25,892,000 | |
| 64,830,000 | |
| 49,971,000 | |
| 33,144,000 | |
| 31,722,548 | |
| -28,251,452 | |
| -42,574,452 | |
| -50,403,452 | |
| -83,755,000 | |
| -88,193,000 | |
| -79,601,000 | |
| -74,614,000 | |
| -55,048,000 | |
| -41,023,000 | |
| -37,115,000 | |
| -33,445,000 | |
| -43,613,000 | |
| -44,535,000 | |
| -42,457,000 | |
| -38,404,000 | |
| -28,553,000 | |
| -25,859,000 | |
| -23,766,000 | |
| -20,755,000 | |
| -19,940,000 | |
| -18,600,000 | |
| -18,780,000 | |
| -18,020,000 | |
| -18,472,000 | |
| -18,637,000 | |
| -17,660,000 | |
| -19,415,000 | |
| -19,118,000 | |
| -17,028,000 | |
| -20,568,000 | |
| -24,084,000 | |
| -34,483,000 | |
| -42,599,000 | |
| -44,636,000 | |
| -46,138,000 | |
| -40,612,000 | |
| -41,045,000 | |
| -41,739,000 | |
| -48,659,000 | |
| -64,239,000 | |
| -73,167,000 | |
| -80,845,000 | |
| -86,573,000 | |
| -83,718,000 | |
| -78,903,000 | |
| -77,810,000 | |
| -58,096,000 | |
| 138,298,000 | |
| 142,285,000 | |
| 161,238,000 | |
| 157,866,000 | |
| -24,271,000 | |
| -17,372,276 | |
| -27,628,804 | |
| -29,331,911 | |
| -28,261,000 | |
| -23,472,195 | |
| 1,633,155 | |
| 3,957,515 | |
| 24,838,076 | |
| 20,533,581 | |
| -555,787 | |
| 1,462,714 | |
| -9,892,277 | |
| -11,137,357 | |
| -13,707,708 | |
| -16,440,603 | |
| -26,246,516 |